The present study was carried out to explore the possible relation of plasma plasminogen activator inhibitor-1 (PAI-1), fibrinogen, and factor VII levels to other risk factors for coronary heart disease (CHD) and to serum sex hormone levels. The study group comprised 48 apparently healthy men. To avoid the confounding factor of obesity, correlations were determined in the 30 men in this group with a body mass index (BMI) <26.4, after controlling for age. PAI-1 correlated with testosterone, estradiol/ testosterone, and free testosterone/testosterone (FT/T), and fibrinogen correlated with FT/T. All three hemostatic factors correlated with glucose and with the ratio of cholesterol/high density lipoprotein cholesterol, while PAI-1 correlated with diastolic blood pressure. To test the effect of obesity, correlations were determined in the entire group of 48 men, which included 18 subjects with a BMI >26.4. All three hemostatic factors correlated with BMI in this group after controlling for age; however, on controlling for testosterone, only PAI-1 correlated with BMI. Fibrinogen correlated with age in both groups after controlling for testosterone or BMI. These correlations support the hypothesis that PAI-1, fibrinogen, and factor Vn are related to other risk factors for CHD and that an alteration in the sex hormone milieu may be the underlying factor linking them. {Arteriosclerosis and Thrombosis 1993;13:467-471) KEY WORDS • sex hormones • estradiol • testosterone • plasminogen activator inhibitor-1 • fibrinogen • factor VII
T he concurrence of major risk factors for coronary heart disease (CHD) in men has suggested a common underlying factor, 1 " 4 and it has been hypothesized that this factor linking them may be an alteration in the sex hormone milieu. 1 -2 Such an alteration has been reported in men in association with hyperinsulinemia, hyperglycemia, hypertension, hypercholesterolemia, hypertriglyceridemia, low high density lipoprotein cholesterol (HDL-C), smoking, and obesity. 5 It has recently been shown that the plasma clotting factors fibrinogen and factor VII are major independent risk factors for CHD, 6 -10 in one study apparently stronger risk factors than cholesterol. 6 In addition, decreased fibrinolysis has been shown to be a risk factor for ischemic heart disease, 6 and a plasma inhibitor of fibrinolysis, the fast-acting plasminogen activator inhibitor (PAI-1), has been reported to be a risk factor for myocardial reinfarction in men. 11 These observations are consistent with the recognition of the importance of thrombosis in the development of CHD. 12 - 16 The effect of sex hormone administration on clotting factors and fibrinolysis 1718 and on the occurrence of myocardial infarction, stroke, and venous thromboembolism 19 -20 sug-gests that the endogenous sex hormone milieu may affect the levels of factors involved in clotting and fibrinolysis and the propensity to thrombosis. Thus, the possibility arises that an alteration in the sex hormone milieu may underlie the elevation of these hemostatic factors. The present study was carried out to determine whether the levels of these hemostatic factors are related to endogenous sex hormone levels and to other risk factors for CHD. In this study, fibrinogen, factor VII, PAI-1, estradiol, total and free testosterone (FT), and sex-hormonebinding globulin (SHBG), as well as other risk factors and hormones, were measured in a group of 48 apparently healthy men in an attempt to determine whether significant correlations were present. Methods Forty-eight apparently healthy men, followed annually as normal control subjects by the Hypertension Center of the New York Hospital-Cornell Medical Center, were studied. None of the subjects were regularly taking any drugs. To remove the effect of obesity in the correlations, data for the 30 men with a body mass index (BMI) <26.4 ("nonobese"), which corresponds to an excess body weight of <20%, 21 were calculated separately.
Sampling and measurement of the hemostatic factors were carried out according to the protocols of the reagent suppliers. Venous blood was drawn between 8:30 and 9:30 AM after an overnight fast into a Vacutainer tube containing no additive and then into a Vacutainer tube containing 0.5 mL buffered sodium citrate to make a final volume of 5 mL. For measurement of the hemostatic factors, the plasma was separated and transferred immediately into two tubes for storage at -70°C; all pipets and storage tubes used were plastic. For the other measurements, the serum was stored at -20°C. One of the plasma samples was used for the measurement of fibrinogen and factor VII, which was carried out on the same day, and the other for PAI-1. Fibrinogen level was estimated by measuring the clotting time of diluted plasma after addition of excess thrombin. With this method, the clotting time is inversely proportional to the fibrinogen concentration. To determine factor VII, the plasma sample was mixed with immunoadsorbed factor VH-deficient plasma and the prothrombin time measured; the amount of correction of the prothrombin time is proportional to the concentration of factor VII in the plasma sample. Materials to assay fibrinogen and factor VII were obtained from the Dade Division, Baxter Healthcare Corp., Miami, Fla. Clotting time in these methods was measured using a BBL fibrometer (Becton Dickinson and Co., Cockeysville, Md.). To measure PAI-1 activity, a photometric PAI-1 kit (Coaset, Kabi Diagnostica, Molndal, Sweden) was used. In this method, a known amount of tissue-type plasminogen activator (t-PA) is added in excess to the plasma sample, where it reacts rapidly with PAI-1 to form an inactive complex. The residual t-PA in the presence of a stimulator activates the plasminogen to plasmin, which is measured photometrically by its action on a chromogenic substrate. The amount of plasmin formed is inversely proportional to the PAI-1 activity of the sample. The intra-assay and interassay coefficients of variation for fibrinogen, factor VII, and PAI-1 were 1.0%, 2.2%, and 4.5%, and 3.9%, 8.3%, and 5.8%, respectively.
All of the hormones were measured by radioimmunoassay (RIA). The methods for measuring estradiol and testosterone were as described. 5 Materials for the RIA of estradiol and insulin were obtained from ICN Biomedicals, Inc., Costa Mesa, Calif.; those for the RIA of testosterone, nonprotein-bound FT, and dehydroepiandrosterone sulfate (DHEAS) were obtained from Diagnostic Products Corp., Los Angeles. Materials for the immunoradiometric assay of SHBG were from Farmos Diagnostica, Oulunsalo, Finland. Glucose was measured using hexokinase. Cholesterol was measured enzymatically, as was the cholesterol in the supernatant after phosphotungstic acid precipitation of serum in the measurement of high density lipoprotein cholesterol.
In the statistical analysis, partial correlations and means and standard deviations were calculated using SPSS programs on an Apple Macintosh SE/30 computer. Significance level was based on a two-tailed test. A probability value of less than or equal to 0.05 was considered significant.
Results
The mean values with standard deviation and range of the variables measured in the 30 nonobese men are shown in Table 1 . Table 2 shows the correlation coefficients, controlled for age, of PAI-1 and the clotting factors with other variables and with each other in the 30 nonobese men. PAI-1 and fibrinogen showed significant correlations with the sex hormones after controlling for age. PAI-1 Even though insulin correlated strongly with E/T by partial correlation after controlling for age and BMI (r=0.68, /?<0.001) in the nonobese group, insulin did not correlate with PAI-1, fibrinogen, or factor VII ( Table 2) . As a test of the validity of the correlations found, correlations were calculated between the sex hormones and other variables and compared with correlations found in previous studies from this laboratory. The results, shown in Table 3 , are similar, even as to the strength of the correlations, with previous studies. As found previously, Discussion Although the present study was carried out in a group of healthy men for whom the range of the variables is limited, significant correlations of plasma PAI-1, fibrinogen, and factor VII emerged. The correlations of these factors with major risk factors for CHD support the hypothesis that major risk factors for CHD are associated with each other and that they are linked by a common underlying factor. 12 In the nonobese group after controlling for age, all three hemostatic factors correlated with glucose and with the cholesterol/ HDL-C ratio. PAI-1 also correlated with diastolic blood pressure and with marginal significance with fibrinogen. In the larger group, which included obese men, after controlling for age the three factors correlated with BMI, but only PAI-1 correlated after controlling for testosterone. Fibrinogen correlated with age in both groups. Others have also reported correlations, many independent, between these hemostatic factors and major risk factors for CHD in men. Fibrinogen has been reported to correlate with factor VII, 6 glucose, 43 It has been hypothesized that the underlying factor linking these risk factors for CHD is an increase in E/T or some closely related alteration.
1 -2 In the present study, PAI-1 correlated negatively with testosterone and with marginal significance with SHBG and positively with E/T and FT/T. Testosterone propionate administration has been reported to increase fibrinolytic activity 18 and stanozolol to decrease inhibition of t-PA. 44 In addition, an inverse correlation has been reported in healthy men between fibrinolytic capacity and E/T 45 and between a2-antiplasmin and testosterone 37 and a positive correlation between a2-antiplasmin and E/T. 37 Furthermore, Caron et al 46 found an inverse correlation between PAI-1 and plasma testosterone in men. Fibrinogen correlated positively with FT/T. Since cigarette smoking, which was not studied, may raise both the fibrinog en 8,25-28,3i-33 anc j testosterone 47 -48 levels in men, it could have confounded a fibrinogen-testosterone correlation. Although in the present study factor VII correlated with risk factors for CHD, it showed no correlations with the sex hormones. Others, however, found that factor VII correlated negatively with testosterone 35 - 37 and positively with E/T 37 in men. Also, the factor VII and fibrinogen levels have been reported to be elevated after contraceptive pill use in women 17 and the factor VII level to be increased about 15-fold in late pregnancy. 49 With the strong correlation of E/T with insulin in men noted previously, 1 -5 it is not surprising that risk factors for CHD that correlate with the sex hormones also correlate with insulin. Thus, others have suggested insulin as the underlying factor linking these risk factors.
Insulin has been reported to stimulate PAI-1 synthesis in vitro but to result in no increase in PAI-1 levels when infused. 50 The results of this study, therefore, are consistent with the hypothesis that PAI-1, fibrinogen, and factor VII are related to other major risk factors for CHD and that an alteration in the sex hormone milieu may be the common underlying factor linking them.
